Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis
Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis: a Randomized Intra-individual Trial
Sponsor: Merete Haedersdal
Listed as NCT05057117, this PHASE4 trial focuses on Hyperhidrosis Primary Focal Axilla and remains completed. Sponsored by Merete Haedersdal, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jun 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Feb 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE4
-
Sep 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
▶ Show 2 earlier versions
-
Apr 2022 — Sep 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Apr 2022 [monthly]
Not Yet Recruiting PHASE4
First recorded
Sep 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Merete Haedersdal
For direct contact, visit the study record on ClinicalTrials.gov .